States have largely dismissed weakening policies, but legislatures are likely to continue considering vaccine-related bills, which may allow public health leaders to work collaboratively toward improving vaccination rates and bolster the ...
The 2019-2020 flu season had approximately 5 million fewer illnesses than the previous year. Thanks to COVID-19 mitigation efforts like social distancing and increased handwashing—coupled with a higher rate of flu vaccinations among the ...
With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To help navigate the new legislative ...
In anticipation of the upcoming presidential election in November, the Republican and Democratic National Committees released their platforms. These platforms provide an overview of values, policies, positions, and principles on various ...
ASTHO's mission is to support, equip, and advocate for state and territorial health officials in their work of advancing the public's health and well-being. To that end, here are the 12 most popular resources our members, partners, ...
Throughout the COVID-19 pandemic, the de Beaumont Foundation has worked closely with organizations like ASTHO to support and strengthen public health. The foundation has produced several publications and guides to support public health ...
As the U.S. continues to undertake the largest vaccination campaign in almost a century, it has required government at all levels to surge workforce capacity. The federal government, states, territories, and local jurisdictions are acting ...
On Aug. 23, 2021, the FDA announced full approval of Pfizer and BioNTech’s mRNA vaccine for COVID-19. ASTHO has answers to five key questions about the approval and what it means for state and territorial health officials: What does the ...
Scientists are working quickly to develop a safe and effective vaccine to provide immunity to COVID-19. Once a vaccine is approved, it will likely be imperative for states to authorize as many health care professionals to administer it, ...
Public health officials from all levels of government are working to respond to the existing outbreak of monkeypox, while preparing for the potential of more widespread transmission.
Anticipating a rapid deployment of COVID-19 vaccines as they are authorized, the CDC developed COVID-19 Vaccination Program Operational Guidance in collaboration with state and local jurisdictions to outline how each jurisdiction will make ...
Vaccines are one of the greatest public health achievements of the last century, as well as some of the most powerful and cost-effective tools to prevent disease, disparities, disability, and death among children and adults. The COVID-19 ...
Pharmacies have long been instrumental partners in providing lifesaving vaccines nationwide. As state and territorial health officials evaluate their COVID-19 response, planners must include input from the pharmacy community when ...
As governments and private entities adopt COVID-19 vaccine protocols to protect health and safety, legal challenges are mounting. In some states, policymakers have proactively attempted to limit or prohibit adopting COVID-19 vaccine ...
As the COVID-19 Delta variant surges across the country, public and private employers have started instituting COVID-19 vaccination, testing, and masking protocols for their employees. On July 29, 2021 the White House announced that all ...
This week might have marked the beginning of summer, but many policymakers and health officials have their eye on the upcoming school year and what that might mean in terms of getting students vaccinated against COVID-19. According to a ...
As the number of COVID-19 vaccinations grows, some states are looking at their vaccination rates to determine when to loosen measures that mitigate the spread of COVID-19, such as venue capacity limits, business closure times, and masking ...
Increasing and maintaining vaccine coverage is an important way to prevent the spread of disease and keep communities healthy. This post is an overview of 2019 state vaccine legislative activities.
Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and millions of COVID-19 cases later, states and ...
Human papillomavirus, or HPV, is a common virus that can lead to certain types of cancer later in life. Because of this, some policymakers are working to include the HPV vaccine in school entry immunization requirements to boost ...